AstraZeneca Pharms. LP v. Apotex Corp., 2011-1182

• Decision Date: 24 February 2012
• Docket Number: 2011-1190,2011-1186,2011-1182,2011-1189,2011-1188,2011-1184,2011-1183,2011-1185,2011-1187
• Parties: ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, IPR PHARMACEUTICALS INC., and THE BRIGHAM AND WOMEN'S HOSPITAL, INC., Plaintiffs-Appellants, v. APOTEX CORP., Defendant-Appellee, and AUROBINDO PHARMA LIMITED, Defendant-Appellee, and COBALT PHARMACEUTICALS INC. and COBALT LABORATORIES INC., Defendants-Appellees, and GLENMARK GENERICS INC. USA, Defendant-Appellee, and MYLAN PHARMACEUTICALS INC., Defendant-Appellee, and PAR PHARMACEUTICALS, INC., Defendant-Appellee, and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellee, and TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee, and TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD., Defendants.
• Court: U.S. Court of Appeals — Federal Circuit

ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, IPR PHARMACEUTICALS INC.,and THE BRIGHAM AND WOMEN'S HOSPITAL, INC., Plaintiffs-Appellants,

v. APOTEX CORP., Defendant-Appellee,and AUROBINDO PHARMA LIMITED, Defendant-Appellee,and COBALT PHARMACEUTICALS INC.and COBALT LABORATORIES INC., Defendants-Appellees,and GLENMARK GENERICS INC. USA, Defendant-Appellee,and MYLAN PHARMACEUTICALS INC., Defendant-Appellee,and PAR PHARMACEUTICALS, INC., Defendant-Appellee,and SUN PHARMACEUTICAL INDUSTRIES, LTD., Defendant-Appellee,and TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee,and TORRENT PHARMA INC. and TORRENT PHARMACEUTICALS LTD., Defendants.

2011-1182

2011-1183

2011-1184

2011-1185

2011-1186

2011-1187

2011-1188

2011-1189

2011-1190

United States Court of Appeals for the Federal Circuit

Dated: February 9, 2012

Decided: February 24, 2012

ERRATA

Page 2

Precedential Opinion

Please make the following change:

Page 3, correction of

Shane A. Brunner, Mechant & Gould, P.C. of Madison, Wisconsin, argued for defendant-appellee "Aurobindo Pharma Limited"

H. Ketto Sabharwal to "H. Keeto Sabharwal"